National Bank of Canada’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31K Sell
36
-21,964
-100% -$2M ﹤0.01% 2599
2025
Q4
$2.86M Hold
22,000
﹤0.01% 997
2025
Q3
$2.37M Sell
22,000
-23,000
-51% -$2.51M ﹤0.01% 1045
2025
Q2
$4.15M Hold
45,000
﹤0.01% 987
2025
Q1
$3.99M Hold
45,000
﹤0.01% 940
2024
Q4
$3.46M Buy
+45,000
New +$3.14M ﹤0.01% 1053
2024
Q1
Sell
-10
Closed -$26 2932
2023
Q4
$26 Hold
10
﹤0.01% 2681
2023
Q3
$37 Sell
10
-13
-57% -$71 ﹤0.01% 2737
2023
Q2
$136 Buy
23
+2
+10% +$16 ﹤0.01% 2679
2023
Q1
$254 Hold
21
﹤0.01% 2629
2022
Q4
$189 Hold
21
﹤0.01% 2701
2022
Q3
$1K Sell
21
-27
-56% -$1.24K ﹤0.01% 2644
2022
Q2
$2K Sell
48
-25
-34% -$1.7K ﹤0.01% 2634
2022
Q1
$7K Sell
73
-1,473
-95% -$164K ﹤0.01% 2485
2021
Q4
$227K Buy
+1,546
New +$345K ﹤0.01% 1434

Other funds holding WGS

National Bank of Canada's WGS Position: Q1 2026 in Review

National Bank of Canada reduced its GeneDx Holdings (WGS) stake by 100% in Q1 2026, selling an estimated $2M and leaving 36 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

National Bank of Canada first reported a position in WGS in Q4 2021 and has held it in 15 quarters since. The position peaked at $4.15M in Q2 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • National Bank of Canada held 36 shares of GeneDx Holdings worth $2.31K as of Q1 2026.
  • National Bank of Canada sold 21,964 GeneDx Holdings shares in Q1 2026, an estimated $2M.
  • GeneDx Holdings made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2599 holding.
  • National Bank of Canada first reported a position in GeneDx Holdings in Q4 2021 and has held it in 15 quarters since.
  • National Bank of Canada's GeneDx Holdings position peaked at $4.15M in Q2 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.